Publications by authors named "Michelle Degeeter"

Claim this Profile
A
Association between the North Carolina Medical Board opioid guideline update and opioid prescriptions in Medicare Part D beneficiaries.
Chris Gillette, Mark A Bush, Kate M L Rogers, Geoffrey Mospan, Kimberly Nealy, Michelle DeGeeter

J Opioid Manag· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Pharmacist Intervention on Weight Parameters and A1c Compared to Standard Patient Care.
Michelle DeGeeter, Shawn Riser Taylor, Ece Ilkiz Okarlton, Jamie Ellex, Christian Dolder

J Pharm Technol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency Providers' Opioid Prescribing Behaviors Among Medicare Part D Beneficiaries in North Carolina, 2013-2014: Medication Utilization and Costs.
Brittany Williams, Geoffrey Mospan, Rebecca Seabock, Chris Gillette, Michelle DeGeeter

N C Med J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.
Michelle DeGeeter, Bobbie Williamson

J Pharm Pract· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preceptor perceptions of fourth year student pharmacists' abilities regarding patient counseling on therapeutic lifestyle changes.
Shawn Riser Taylor, Michelle DeGeeter, Jennifer A Wilson, Kim I Leadon, Philip T Rodgers

Curr Pharm Teach Learn· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy students' ability to identify plagiarism after an educational intervention.
Michelle Degeeter, Kira Harris, Heather Kehr, Carolyn Ford, Daniel C Lane

Am J Pharm Educ· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.
Cassie L Boland, Michelle Degeeter, Donald S Nuzum, Maria Tzefos

Ann Pharmacother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis